Idéal Investisseur Connexion Connexion
Français English
CAC 40 : Market closed
7 927,75 pts
-1.89%


Last updated : 20/11/2026 - 17h35
🏠 Home   ➤    Stock news

Sanofi shares lead the CAC 40, up 20% over one month against the trend

The pharmaceutical company is resisting the nervousness shaking stock markets after the correction in technology stocks. The stock stands out from a Parisian market trending lower, following the European authorization of a new vaccine.


Sanofi shares lead the CAC 40, up 20% over one month against the trend

A lead on the Parisian market confirmed by a sharp monthly rebound

Sanofi shares gain 1.65% to €85.17 during the session, while the CAC 40 falls 1.32% and the SBF 120 drops 1.38%. The stock holds first place in the index, ahead of Danone (+1.42%), while STMicroelectronics (-6.55%) loses the most ground.

The session follows a 3.19% decline over the week, but the stock remains up nearly 20% over one month and stays above its moving averages: the 200-day moving average (MM200) is at €77.03, a gap of 10.57% from the share price.

The RSI at 62 does not indicate excessive tension. The €88.32 resistance remains the closely watched upper level, while the 20-day moving average (MM20), at €82.96, sits 2.66% below the share price.

The European authorization of VaxRabeo, a new rabies vaccine, adds to the context

The European Commission has granted the first marketing authorization for VaxRabeo, the new rabies vaccine, announced by Sanofi on November 19. It covers pre-exposure and post-exposure prophylaxis for all age groups, and follows the positive opinion issued on September 17 by the Committee for Medicinal Products for Human Use of the European Medicines Agency.

The stock had nevertheless declined the previous day despite this announcement, which makes the session's performance all the more notable.

In a context of tension in artificial intelligence-related stocks, with the VIX at 29.47, the share is moving against the American indices, which closed Thursday down about 2%. According to the consensus of the analysts surveyed, the stock trades at about 9.6 times earnings for the current fiscal year.

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning ✓ Euronext data ✓ AI-powered analysis


Sector Pharmacie et biotechnologies › Pharmacie, vaccins et santé animale


Context

Period
  • Period: 9M 2026
Key reported figures
  • Revenue: 36 550 millions d'euros
  • Quarterly revenue: 36 550 millions d'euros
  • Revenue growth: 13,1 %
  • Net income: 4 979 millions d'euros
  • Free cash flow: 6 993 millions d'euros
  • 12 201 millions d'euros

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
✓ Avant 9h00 ✓ 1000+ inscrits ✓ 100% gratuit
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours sur les valeurs Euronext, chaque matin avant 9h.
tendance · 6 séances
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours